ProShares Ultra NASDAQ Biotechnology
BIB
BIB
11 hedge funds and large institutions have $3.58M invested in ProShares Ultra NASDAQ Biotechnology in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Holders
11
Holding in Top 10
–
Calls
–
Puts
$15K
Top Buyers
| 1 | +$602K | |
| 2 | +$491K | |
| 3 | +$254K | |
| 4 |
Jane Street
New York
|
+$231K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$18.1K |
Top Sellers
| 1 | -$998K | |
| 2 | -$36K | |
| 3 | -$31.8K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$28.9K |